GO:0001980 regulation of systemic arterial blood pressure by ischemic conditions: CNS Ischemic Response, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001980 describes the biological process that modulates systemic arterial blood pressure through detection of carbon dioxide levels in the brain stem, activating sympathetic vasoconstriction.
• The CNS ischemic response is a last-ditch sympathetic mechanism that raises blood pressure when cerebral perfusion is threatened by ischemia.
• Key molecular players include hypoxia-inducible factors (HIFs), especially HIF-1alpha and HIF-2alpha, which mediate cellular oxygen sensing.
• Cerebral blood flow regulation involves complex hemodynamic and metabolic signaling that can be studied with arterial monitoring devices in large-animal models.
• Dysregulation of this process contributes to ischemic stroke, spinal cord injury-related cardiovascular instability, and age-related ventricular-arterial uncoupling.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate genes in this pathway.
Description
The regulation of systemic arterial blood pressure by ischemic conditions (GO:0001980) is a fundamental homeostatic process in which the brain stem senses elevated carbon dioxide levels during ischemia and triggers a powerful sympathetic vasoconstrictor response. This process, often called the CNS ischemic response, represents one of the most potent mechanisms for restoring blood pressure when cerebral perfusion is compromised. Understanding this pathway is critical for researchers studying stroke, traumatic brain injury, spinal cord injury, and cardiovascular collapse.
regulation of systemic arterial blood pressure by ischemic conditions At A Glance
| GO ID | GO:0001980 |
|---|---|
| GO term | regulation of systemic arterial blood pressure by ischemic conditions |
| Ontology | biological_process |
| Synonym | CNS ischemic response; ischemic control of blood pressure; ischemic regulation of systemic arterial blood pressure |
| Major function | Modulates systemic arterial blood pressure via brain stem CO2 detection and sympathetic vasoconstriction |
| Related physiology | Cerebral blood flow regulation, oxygen sensing, and sympathetic outflow |
| Key molecular sensors | Hypoxia-inducible factors (HIFs), brain stem chemoreceptors |
| Clinical relevance | Ischemic stroke, spinal cord injury, cardiovascular collapse |
What Is GO:0001980?
GO:0001980 is defined as the process that modulates blood pressure by the detection of carbon dioxide levels in the brain stem. Increased CO2 levels activate the sympathetic vasoconstrictor mechanism, increasing the force with which blood flows through the circulatory system. This process is synonymous with the CNS ischemic response, ischemic control of blood pressure, and ischemic regulation of systemic arterial blood pressure.
Why Is regulation of systemic arterial blood pressure by ischemic conditions Important in Cell Biology?
GO:0001980 is essential because it represents a life-saving physiological reflex that maintains cerebral perfusion during ischemic emergencies. When cerebral blood flow falls, CO2 accumulates in the brain stem, activating sympathetic vasoconstriction to raise systemic blood pressure and restore perfusion. This process is particularly relevant in critical care settings, where monitoring and supporting this reflex can mean the difference between recovery and irreversible brain damage.
• Critical for survival during ischemic events such as stroke and cardiac arrest.
• Involved in spinal cord injury-related cardiovascular dysregulation.
• Mediated by oxygen-sensing pathways including HIF signaling.
• Studied using arterial monitoring devices in large-animal models.
• Relevant to age-related changes in ventricular-arterial coupling.
• Target for gene therapy approaches in cerebrovascular disease.
• Provides insight into cerebral hemodynamics and autoregulation.
• Potential therapeutic target for blood pressure management in critical care.
What Happens During regulation of systemic arterial blood pressure by ischemic conditions?
Detection of carbon dioxide in the brain stem
In simple terms: The brain stem senses when carbon dioxide builds up because blood flow is too low.
Brain stem chemoreceptors detect increased CO2 levels resulting from ischemia, initiating the CNS ischemic response. This detection is a key trigger for the subsequent sympathetic activation.
Activation of sympathetic vasoconstrictor mechanism
In simple terms: The nervous system tells blood vessels to tighten up.
Elevated CO2 activates sympathetic outflow, causing vasoconstriction that increases systemic vascular resistance and raises blood pressure. This sympathetic activation is a hallmark of the ischemic response.
Increase in force of blood flow through the circulatory system
In simple terms: Blood is pushed harder through the body to restore circulation.
The sympathetic vasoconstriction increases the force with which blood flows through the circulatory system, thereby elevating systemic arterial blood pressure. This helps restore perfusion to ischemic tissues, particularly the brain.
Integration with cerebral blood flow regulation
In simple terms: The brain adjusts its own blood supply in response to ischemia.
Cerebral hemodynamics and autoregulation mechanisms work in concert with the ischemic response to maintain adequate brain perfusion. After spinal cord injury, this regulation can be impaired, leading to cardiovascular instability.
Oxygen sensing and HIF-mediated signaling
In simple terms: Cells sense low oxygen and turn on survival genes.
Hypoxia-inducible factors (HIFs) mediate cellular responses to low oxygen, which can influence the ischemic response and blood pressure regulation. This molecular oxygen-sensing pathway is critical for adapting to ischemic conditions.
Key Genes Involved in GO:0001980 regulation of systemic arterial blood pressure by ischemic conditions
The following genes and proteins are involved in the regulation of systemic arterial blood pressure by ischemic conditions, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HIF1A | Oxygen sensing and hypoxia response | Knockout models to study ischemic response |
| EPAS1 (HIF2A) | Oxygen sensing and vascular tone | Point mutations to assess HIF-2alpha function |
| VHL | Regulation of HIF degradation | Knockout to stabilize HIFs |
| NOS1 | Nitric oxide synthesis in brain stem | KO models for blood pressure regulation |
| NOS2 | Inducible nitric oxide synthase in inflammation | Overexpression to study vasodilation |
| NOS3 | Endothelial nitric oxide synthase | Knock-in for eNOS function |
| ADRB1 | Beta-1 adrenergic receptor in sympathetic response | KO to study sympathetic vasoconstriction |
| ADRB2 | Beta-2 adrenergic receptor | Point mutation for receptor signaling |
| AGTR1 | Angiotensin II receptor type 1 | Knockout for blood pressure regulation |
| ACE | Angiotensin-converting enzyme | Overexpression for hypertension models |
| EDN1 | Endothelin-1, potent vasoconstrictor | Knock-in for endothelin signaling |
| EDNRA | Endothelin receptor type A | KO to study vasoconstriction |
| VEGFA | Vascular endothelial growth factor | Overexpression for angiogenesis |
| KCNQ1 | Potassium channel in vascular smooth muscle | Point mutation for channelopathy |
| SCN5A | Sodium channel in cardiac conduction | Knock-in for arrhythmia models |
| ATP1A1 | Na+/K+-ATPase in vascular tone | KO for ion transport studies |
| CACNA1C | Calcium channel in vascular smooth muscle | Point mutation for calcium signaling |
How Is regulation of systemic arterial blood pressure by ischemic conditions Regulated?
The process is regulated by oxygen-sensing pathways, particularly HIF-mediated signaling, which responds to low oxygen levels. Sympathetic nervous system activity and nitric oxide signaling also modulate the response. Age-related changes in ventricular-arterial coupling can affect the efficacy of this regulation.
regulation of systemic arterial blood pressure by ischemic conditions and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HIF1A | Ischemic stroke, hypoxia | Knockout mouse model |
| EPAS1 | Pulmonary hypertension, hypoxia | Point mutation knock-in |
| NOS3 | Endothelial dysfunction, hypertension | Overexpression model |
| AGTR1 | Hypertension, cardiovascular disease | Knockout rat model |
| SCN5A | Arrhythmia, sudden cardiac death | Knock-in mouse model |
Ischemic stroke
Disruption of the CNS ischemic response can worsen outcomes in ischemic stroke by failing to restore adequate cerebral perfusion. Gene therapy approaches targeting cerebrovascular disease aim to enhance these protective mechanisms.
Spinal cord injury
After spinal cord injury, regulation of cerebral blood flow and systemic blood pressure is often impaired, leading to cardiovascular instability. Understanding GO:0001980 is crucial for managing these patients.
Age-related cardiovascular changes
Age-related changes in ventricular-arterial coupling can alter the effectiveness of blood pressure regulation during ischemia, contributing to heart failure and other cardiovascular diseases.
From regulation of systemic arterial blood pressure by ischemic conditions-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does HIF1A mediate the CNS ischemic response? | HIF1A knockout mouse |
| What is the role of EPAS1 in blood pressure regulation? | EPAS1 point mutation knock-in |
| Can overexpression of NOS3 improve ischemic outcomes? | NOS3 overexpression transgenic model |
| How does AGTR1 contribute to hypertension? | AGTR1 knockout rat |
| Does SCN5A mutation affect cardiac conduction during ischemia? | SCN5A knock-in mouse |
| What is the effect of VHL deletion on HIF signaling? | VHL conditional knockout |
How to Study the regulation of systemic arterial blood pressure by ischemic conditions Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Arterial monitoring device | Systemic arterial blood pressure | Swine validation studies |
| Transcranial Doppler | Cerebral blood flow velocity | Cerebrovascular reactivity assessment |
| HIF reporter assay | Hypoxia-inducible factor activity | Oxygen sensing studies |
| Gene knockout | Loss-of-function effects | Causal gene testing |
| Knock-in | Point mutation effects | Disease modeling |
| Overexpression | Gain-of-function effects | Therapeutic target validation |
| RNA-seq | Transcriptional changes | Pathway analysis |
| Proteomics | Protein expression changes | Biomarker discovery |
Arterial monitoring in large-animal models
Compact arterial monitoring devices can be used in swine models to validate blood pressure changes during ischemic conditions. This approach provides real-time hemodynamic data.
Cerebral blood flow measurement
Techniques such as transcranial Doppler and nuclear medicine methods assess cerebral hemodynamics and autoregulation. These are essential for studying the ischemic response.
Molecular oxygen-sensing assays
HIF stabilization and reporter assays measure cellular responses to hypoxia, linking molecular oxygen sensing to systemic blood pressure regulation.
Genetic manipulation in animal models
Knockout, knock-in, and transgenic models allow causal testing of genes involved in the ischemic response.
How CRISPR Can Be Used to Study GO:0001980 regulation of systemic arterial blood pressure by ischemic conditions
Knockout
CRISPR knockout of genes such as HIF1A or NOS3 can reveal their essential roles in the CNS ischemic response. These models help determine causality in blood pressure regulation.
Point Mutation
Introducing specific point mutations in genes like EPAS1 or SCN5A allows study of subtle functional changes relevant to ischemic responses.
Knock-in
Knock-in of reporter tags or human disease variants into loci such as AGTR1 or EDN1 enables tracking and functional analysis.
Overexpression
Overexpression of protective genes like VEGFA or NOS3 can test their ability to enhance ischemic tolerance and blood pressure regulation.
How EDITGENE Supports regulation of systemic arterial blood pressure by ischemic conditions Research
Researchers studying regulation of systemic arterial blood pressure by ischemic conditions-related genes often need to determine whether a candidate gene is causally involved in the response or merely a bystander. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of systemic arterial blood pressure by ischemic conditions research.
Frequently Asked Questions About regulation of systemic arterial blood pressure by ischemic conditions
What is GO:0001980?
GO:0001980 is the biological process that modulates systemic arterial blood pressure by detecting carbon dioxide levels in the brain stem and activating sympathetic vasoconstriction.
What genes are involved in regulation of systemic arterial blood pressure by ischemic conditions?
Key genes include HIF1A, EPAS1, VHL, NOS1, NOS2, NOS3, ADRB1, ADRB2, AGTR1, ACE, EDN1, EDNRA, VEGFA, KCNQ1, SCN5A, ATP1A1, and CACNA1C.
How is the CNS ischemic response triggered?
It is triggered by increased carbon dioxide levels in the brain stem during ischemia, which activates the sympathetic vasoconstrictor mechanism.
What is the role of HIF1A in this process?
HIF1A mediates oxygen sensing and hypoxia responses that can influence blood pressure regulation during ischemic conditions.
Can CRISPR be used to study GO:0001980?
Yes, CRISPR knockout, knock-in, and overexpression models allow causal testing of genes involved in this pathway.
What diseases are associated with dysregulation of this process?
Ischemic stroke, spinal cord injury, and age-related cardiovascular changes are associated with dysregulation of this process.
How is cerebral blood flow regulated during ischemia?
Cerebral hemodynamics and autoregulation mechanisms work with the CNS ischemic response to maintain brain perfusion.
What animal models are used to study this process?
Swine models with arterial monitoring devices and rodent knockout models are commonly used.
What methods measure blood pressure regulation in this context?
Arterial monitoring devices, transcranial Doppler, and molecular oxygen-sensing assays are used.
Why is GO:0001980 important for critical care?
It represents a life-saving reflex that restores blood pressure during ischemic emergencies, critical for patient survival.
Conclusion
GO:0001980 regulation of systemic arterial blood pressure by ischemic conditions is a vital homeostatic process with profound implications for cardiovascular and cerebrovascular health. Understanding its molecular mechanisms, particularly the role of oxygen-sensing pathways and sympathetic activation, can lead to new therapeutic strategies for ischemic diseases. EDITGENE offers comprehensive CRISPR services to accelerate research in this field.
References
- 1. Lussier G et al.. 2024. Compact Arterial Monitoring Device Use in Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): A Simple Validation Study in Swine.. Cureus 16(10):e70789 PMID: 39493181
- 2. Bateman RM et al.. 2016. 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.. Crit Care 20(Suppl 2):94 PMID: 27885969
- 4. Weihl C et al.. 1999. Gene therapy for cerebrovascular disease.. Neurosurgery 44(2):239-52; discussion 253 PMID: 9932877
- 5. Phillips AA et al.. 2013. Regulation of cerebral blood flow after spinal cord injury.. J Neurotrauma 30(18):1551-63 PMID: 23758347
- 6. Semenza GL. 2014. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology.. Annu Rev Pathol 9:47-71 PMID: 23937437
- 7. Rudziński W et al.. 2007. Cerebral hemodynamics and investigations of cerebral blood flow regulation.. Nucl Med Rev Cent East Eur 10(1):29-42 PMID: 17694500
- 8. Kass DA. 2002. Age-related changes in venticular-arterial coupling: pathophysiologic implications.. Heart Fail Rev 7(1):51-62 PMID: 11790922
